performance for 3-month period ended June 30, 2017. To Managing Director The Stock Exchange of Thailand The Operating results of the company and its subsidiaries for the 3-month period ended June 30, 2017 as in
Microsoft Word - letQ217MD&AE .doc ( Translation ) 11st August 2017 Subject: Management Discussion and Analysis (MD&A) for the 2nd quarter and 6-month periods of year 2017 To: Managing Director of
2016. To : The director of the Stock Exchange of Thailand Ramkhamhaeng Hospital Public Company Limited would like to clarify the operation results, as follows: 1. Ramkhamhaeng Hospital Public Company
Leyland’s business agreed between the Subsidiary and the Sellers at THB 315,000,000 subtract with loan from Leyland’s director. The details are summarized as follows: 1. Loan from a director of Leyland (Mr
November 8, 2017 Reference no. RWI /RY/061/2560 Subject : Management’s Discussion and Analysis of Business Operations of the Third Quarter of 2017 Dear The Director and Manager of the Stock Exchange
, Samutprakarn 10280, Thailand Tel. 66 2323 1085..96 Fax. 66 2323 9283 (Translation) 13 November 2017 Subject: Management Discussion and Analysis (MD&A) for the third quarter ended 30 September 2017 To: Director
Microsoft Word - letQ317MD&AE .doc ( Translation ) 13rd November 2017 Subject: Management Discussion and Analysis (MD&A) for the 3rd quarter and 9-month periods of year 2017 To: Managing Director of
: EIC-AD052/2017 November 13, 2017 Subject: Management Discussion and Analysis of the Operating Performance for Quarter 3 Ending September 30, 2017 To: President and Director The Stock Exchange of
of 30 September 2017 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the nine-month
) February 14, 2017 Re : Report the operating result for the year ended December 31 ,2017 by more than 20 percent. To : Director and Manager the Stock Exchange of Thailand Approved by the Board of Directors of